Qingdao Haier Biomedical Co.,Ltd.’s Net Profit Dropped 33.7% in First Three Quarters of 2022

Qingdao Haier Biomedical Co.,Ltd. (青岛海尔生物医疗股份有限公司) (688139.SH) reported a net profit of 464.5 million yuan in the first three quarters of 2022, down 33.7% year-on-year.

Meanwhile, the company posted 2.1 billion yuan in revenue, up 36.5% year-on-year.

At the end of the reporting period, it had 5.1 billion yuan in total assets and 1.2 billion yuan in total liabilities, with a liability-to-asset ratio of 23.5%.